A chimeric (human/mouse) monoclonal antibody (mAb) has been developed and its potential to protect from or cure a Venezuelan equine encephalomyelitis virus (VEEV) infection was evaluated. The chimeric mAb, ch3B4C-4, has virus-neutralizing capacity
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1035 | Recombinant Anti-VEEV Antibody | ELISA, WB, FC, FuncS | IgG |
MHH-1035 | Recombinant Human Anti-VEEV Antibody | FC, WB, FuncS | IgG |
MOB-0244MC | Rabbit Anti-VEEV Antibody | WB, ELISA | |
HPAB-0767-WJ | Recombinant Mouse Anti-VEEV Antibody (1A3B7) | WB | Mouse IgG2a |
HPAB-0768-WJ | Recombinant Human Anti-VEEV Antibody (h1A3B7) | FC | Human IgG1 |
There are currently no Customer reviews or questions for FAMAB-0290-YC-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.